CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Myungmoon Pharmaceutical Company Limited Company Snapshot
Myungmoon Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Myungmoon Pharmaceutical Company Limited with three other companies in this sector in South Korea: Celltrion Pharm Incorporated (2017 sales of 135.86 billion Korean Won [US$120.24 million] of which 100% was Pharmaceutical), JW Life Science Corp (143.60 billion Korean Won [US$127.09 million] ), and Nutri Biotech Co Ltd (136.35 billion Korean Won [US$120.67 million] of which 100% was Manufacture & Sales of Health Food).

Sales Analysis. During the year ended December of 2017, sales at Myungmoon Pharmaceutical Company Limited were 140.14 billion Korean Won (US$124.02 million). This is a decrease of 1.4% versus 2016, when the company's sales were 142.18 billion Korean Won. Contributing to the drop in overall sales was the 1.6% decline in Manufacturing and Sale of Pharmaceuticals, from 138.13 billion Korean Won to 135.92 billion Korean Won. . However, these declines were partially offset by the increase in sales of Severce Segment (up 4.1% to 4.22 billion Korean Won) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Myungmoon Pharmaceutical Company Limited
  Stock Performance Chart for Myungmoon Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (8/10/2018): 6,300.00
(Figures in Korean Won)
1 Week -3.8%   13 Weeks -4.1%  
4 Weeks -20.1%   52 Weeks 4.1%  
 
Myungmoon Pharmaceutical Company Limited Key Data:
  Ticker: 017180 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 140,137,942,908
(Year Ending Jan 2018).
Employees: 481
  Currency: Korean Won Market Cap: 153,671,716,800
  Fiscal Yr Ends: December Shares Outstanding: 24,392,336
  Share Type: Common Closely Held Shares: 6,402,099
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.